• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDaraprim

Daraprim

Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
Health
Martin Shkreli Seriously Didn’t Care About Jacking Up Drug Prices
By Laura LorenzettiFebruary 3, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Leadership
Martin Shkreli Asks Court to Consider Blocking Subpoena
By ReutersJanuary 23, 2016
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Finance
Here’s How Much Martin Shkreli Is Actually Worth
By Jen WiecznerJanuary 8, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health
Martin Shkreli’s Twitter Account Hacked
By Reuters and Aaron TaskDecember 20, 2015
US-CRIME-JUSTICE-SHKRELI
Health
Turing Replaces Martin Shkreli with Interim CEO
By Laura LorenzettiDecember 18, 2015
US-CRIME-JUSTICE-SHKRELI
Health
Martin Shkreli Is Reportedly Stepping Down as Turing CEO
By Benjamin SnyderDecember 18, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Leadership
Martin Shkreli’s 15 Minutes Are Up
By Geoff ColvinDecember 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Health
How Pharmacies Are Dealing with Daraprim After Martin Shkreli’s Arrest
By ReutersDecember 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Finance
Pharma CEO Martin Shkreli Arrested for Securities Fraud
By Geoffrey SmithDecember 17, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Express Scripts is Taking on Turing Pharmaceuticals’ 5,000% Price Hike
By Claire GrodenDecember 1, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Turing Offers Hospitals Discounts on Daraprim Price
By Laura LorenzettiNovember 25, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Turing Says it Will Lower Daraprim Price by the End of the Year
By Laura LorenzettiNovember 4, 2015
Why the drug price scandal won’t be enough to keep down prices
Retail
Why the drug price scandal won’t be enough to keep down prices
By Laura LorenzettiOctober 26, 2015
Imprimis Turing Drug
Health
This company is offering a $1 alternative to Turing’s $750 drug
By Laura LorenzettiOctober 23, 2015
MSMB Capital Management CIO Martin Shkreli
Health
This super-expensive drug is getting a $1 rival
By Benjamin SnyderOctober 23, 2015
1
  • 1
  • 2
2
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
'Skills nobody can take': Meet a 20-year-old with a 4.5 GPA who skipped college for technical school to land an 'AI-proof' careerplaceholder alt text
By Muskaan ArshadSeptember 22, 2026
Middle East
China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment schemeplaceholder alt text
By Jason MaSeptember 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.